Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 24
1966 48
1967 31
1968 60
1969 53
1970 51
1971 62
1972 50
1973 43
1974 39
1975 25
1976 34
1977 34
1978 53
1979 58
1980 63
1981 69
1982 73
1983 88
1984 42
1985 54
1986 51
1987 53
1988 51
1989 42
1990 92
1991 52
1992 45
1993 60
1994 47
1995 85
1996 100
1997 114
1998 124
1999 162
2000 123
2001 168
2002 176
2003 172
2004 172
2005 147
2006 147
2007 160
2008 171
2009 164
2010 202
2011 246
2012 255
2013 256
2014 213
2015 286
2016 272
2017 265
2018 267
2019 198
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

5,898 results
Results by year
Filters applied: . Clear all
Page 1
Dry powder inhalable formulations for anti-tubercular therapy.
Parumasivam T, Chang RY, Abdelghany S, Ye TT, Britton WJ, Chan HK. Parumasivam T, et al. Adv Drug Deliv Rev. 2016 Jul 1;102:83-101. doi: 10.1016/j.addr.2016.05.011. Epub 2016 May 17. Adv Drug Deliv Rev. 2016. PMID: 27212477 Review.
Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis.
Olaru ID, Heyckendorf J, Andres S, Kalsdorf B, Lange C. Olaru ID, et al. Eur Respir J. 2017 May 21;49(5):1700742. doi: 10.1183/13993003.00742-2017. Print 2017 May. Eur Respir J. 2017. PMID: 28529207 Free article. No abstract available.
End TB with precision treatment!
van der Burgt EP, Sturkenboom MG, Bolhuis MS, Akkerman OW, Kosterink JG, de Lange WC, Cobelens FG, van der Werf TS, Alffenaar JW. van der Burgt EP, et al. Eur Respir J. 2016 Feb;47(2):680-2. doi: 10.1183/13993003.01285-2015. Eur Respir J. 2016. PMID: 26828056 Free article. No abstract available.
5,898 results
Jump to page
Feedback